Logo image of ZBRA

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Stock Fundamental Analysis

NASDAQ:ZBRA - Nasdaq - US9892071054 - Common Stock - Currency: USD

327.14  -3.21 (-0.97%)

After market: 327.14 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ZBRA. ZBRA was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. ZBRA has an excellent profitability rating, but there are some minor concerns on its financial health. ZBRA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ZBRA had positive earnings in the past year.
In the past year ZBRA had a positive cash flow from operations.
Each year in the past 5 years ZBRA has been profitable.
Of the past 5 years ZBRA 4 years had a positive operating cash flow.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

The Return On Assets of ZBRA (6.95%) is better than 84.00% of its industry peers.
The Return On Equity of ZBRA (15.14%) is better than 84.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.78%, ZBRA belongs to the top of the industry, outperforming 86.40% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ZBRA is above the industry average of 9.16%.
Industry RankSector Rank
ROA 6.95%
ROE 15.14%
ROIC 10.78%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

The Profit Margin of ZBRA (10.74%) is better than 86.40% of its industry peers.
ZBRA's Profit Margin has declined in the last couple of years.
ZBRA's Operating Margin of 15.51% is amongst the best of the industry. ZBRA outperforms 91.20% of its industry peers.
ZBRA's Operating Margin has been stable in the last couple of years.
ZBRA's Gross Margin of 48.79% is amongst the best of the industry. ZBRA outperforms 84.80% of its industry peers.
In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 15.51%
PM (TTM) 10.74%
GM 48.79%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
Compared to 1 year ago, ZBRA has more shares outstanding
The number of shares outstanding for ZBRA has been reduced compared to 5 years ago.
ZBRA has a better debt/assets ratio than last year.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.33 indicates that ZBRA is not in any danger for bankruptcy at the moment.
ZBRA has a better Altman-Z score (4.33) than 68.80% of its industry peers.
The Debt to FCF ratio of ZBRA is 2.17, which is a good value as it means it would take ZBRA, 2.17 years of fcf income to pay off all of its debts.
ZBRA has a better Debt to FCF ratio (2.17) than 76.00% of its industry peers.
ZBRA has a Debt/Equity ratio of 0.58. This is a neutral value indicating ZBRA is somewhat dependend on debt financing.
ZBRA's Debt to Equity ratio of 0.58 is on the low side compared to the rest of the industry. ZBRA is outperformed by 76.00% of its industry peers.
Even though the debt/equity ratio score it not favorable for ZBRA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.17
Altman-Z 4.33
ROIC/WACC1.18
WACC9.11%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

ZBRA has a Current Ratio of 1.45. This is a normal value and indicates that ZBRA is financially healthy and should not expect problems in meeting its short term obligations.
ZBRA has a Current ratio of 1.45. This is in the lower half of the industry: ZBRA underperforms 76.00% of its industry peers.
A Quick Ratio of 1.02 indicates that ZBRA should not have too much problems paying its short term obligations.
ZBRA has a Quick ratio of 1.02. This is amonst the worse of the industry: ZBRA underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.02
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.66% over the past year.
Measured over the past 5 years, ZBRA shows a small growth in Earnings Per Share. The EPS has been growing by 0.88% on average per year.
ZBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.46%.
ZBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.12% yearly.
EPS 1Y (TTM)68.66%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%41.55%
Revenue 1Y (TTM)17.46%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%11.32%

3.2 Future

The Earnings Per Share is expected to grow by 13.52% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.94% on average over the next years.
EPS Next Y8.63%
EPS Next 2Y11.12%
EPS Next 3Y10.93%
EPS Next 5Y13.52%
Revenue Next Year5.9%
Revenue Next 2Y5.99%
Revenue Next 3Y5.7%
Revenue Next 5Y5.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.27 indicates a rather expensive valuation of ZBRA.
Compared to the rest of the industry, the Price/Earnings ratio of ZBRA indicates a somewhat cheap valuation: ZBRA is cheaper than 73.60% of the companies listed in the same industry.
ZBRA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 19.61 indicates a rather expensive valuation of ZBRA.
68.80% of the companies in the same industry are more expensive than ZBRA, based on the Price/Forward Earnings ratio.
ZBRA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.27
Fwd PE 19.61
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZBRA is valued a bit cheaper than the industry average as 62.40% of the companies are valued more expensively.
ZBRA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ZBRA is cheaper than 86.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.62
EV/EBITDA 18.79
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
ZBRA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.58
PEG (5Y)25.26
EPS Next 2Y11.12%
EPS Next 3Y10.93%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ZBRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (7/11/2025, 8:00:02 PM)

After market: 327.14 0 (0%)

327.14

-3.21 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners93.22%
Inst Owner Change0.02%
Ins Owners0.7%
Ins Owner Change3.57%
Market Cap16.64B
Analysts77.5
Price Target323.98 (-0.97%)
Short Float %1.78%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.19%
Min EPS beat(2)-0.59%
Max EPS beat(2)8.97%
EPS beat(4)3
Avg EPS beat(4)6.32%
Min EPS beat(4)-0.59%
Max EPS beat(4)11.15%
EPS beat(8)6
Avg EPS beat(8)5.43%
EPS beat(12)8
Avg EPS beat(12)3.32%
EPS beat(16)12
Avg EPS beat(16)3.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)-0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-1.39%
Revenue beat(16)8
Avg Revenue beat(16)-0.93%
PT rev (1m)0.62%
PT rev (3m)-19.18%
EPS NQ rev (1m)0.13%
EPS NQ rev (3m)-6.25%
EPS NY rev (1m)-0.34%
EPS NY rev (3m)-5.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 22.27
Fwd PE 19.61
P/S 3.25
P/FCF 16.62
P/OCF 15.61
P/B 4.59
P/tB N/A
EV/EBITDA 18.79
EPS(TTM)14.69
EY4.49%
EPS(NY)16.68
Fwd EY5.1%
FCF(TTM)19.69
FCFY6.02%
OCF(TTM)20.96
OCFY6.41%
SpS100.57
BVpS71.31
TBVpS-14.24
PEG (NY)2.58
PEG (5Y)25.26
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 15.14%
ROCE 12.55%
ROIC 10.78%
ROICexc 12.52%
ROICexgc 62.54%
OM 15.51%
PM (TTM) 10.74%
GM 48.79%
FCFM 19.57%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ROICexc(3y)12.35%
ROICexc(5y)15.17%
ROICexgc(3y)83.03%
ROICexgc(5y)N/A
ROCE(3y)13.49%
ROCE(5y)16.56%
ROICexcg growth 3Y-36.88%
ROICexcg growth 5Y-17.49%
ROICexc growth 3Y-16.79%
ROICexc growth 5Y-8.38%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.17
Debt/EBITDA 2.18
Cap/Depr 38.24%
Cap/Sales 1.27%
Interest Coverage 19.34
Cash Conversion 110.7%
Profit Quality 182.33%
Current Ratio 1.45
Quick Ratio 1.02
Altman-Z 4.33
F-Score8
WACC9.11%
ROIC/WACC1.18
Cap/Depr(3y)40.17%
Cap/Depr(5y)39.59%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.66%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%41.55%
EPS Next Y8.63%
EPS Next 2Y11.12%
EPS Next 3Y10.93%
EPS Next 5Y13.52%
Revenue 1Y (TTM)17.46%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%11.32%
Revenue Next Year5.9%
Revenue Next 2Y5.99%
Revenue Next 3Y5.7%
Revenue Next 5Y5.94%
EBIT growth 1Y52.5%
EBIT growth 3Y-8.88%
EBIT growth 5Y1.11%
EBIT Next Year14.89%
EBIT Next 3Y11.07%
EBIT Next 5Y11.31%
FCF growth 1Y256.23%
FCF growth 3Y-1.88%
FCF growth 5Y8.86%
OCF growth 1Y197.77%
OCF growth 3Y-1.78%
OCF growth 5Y8.14%